These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 1796663

  • 1. [Pharmacokinetics of contraceptive steroids with reference to long-term administration].
    Carol W, Klinger G, Michels W, Boer J, Pocha C.
    Zentralbl Gynakol; 1991; 113(23):1298-303. PubMed ID: 1796663
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.
    Carol W, Klinger G, Jäger R, Kasch R, Brandstädt A.
    Exp Clin Endocrinol; 1992; 99(1):12-7. PubMed ID: 1628691
    [Abstract] [Full Text] [Related]

  • 3. [The effect of physical training on the pharmacokinetics of steroidal contraceptives].
    Klinger G, Seidel E, Carol W, Boer J, Pocha C.
    Zentralbl Gynakol; 1991; 113(22):1240-5. PubMed ID: 1755260
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetics of ethinyl estradiol following the administration of combination contraceptive preparations].
    Carol W, Klinger G, Jäger R, Kasch R.
    Zentralbl Gynakol; 1990; 112(3):135-41. PubMed ID: 2336888
    [Abstract] [Full Text] [Related]

  • 5. [Inter- and intra-individual variability of pharmacokinetic parameters for contraceptive steroids].
    Carol W, Klinger G, Jäger R, Kasch R, Michels W.
    Zentralbl Gynakol; 1991; 113(13):783-7. PubMed ID: 1927130
    [Abstract] [Full Text] [Related]

  • 6. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
    Endrikat J, Blode H, Gerlinger C, Rosenbaum P, Kuhnz W.
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiol.
    Stanczyk FZ, Lobo RA, Chiang ST, Woutersz TB.
    Contraception; 1990 Jan; 41(1):39-53. PubMed ID: 2105872
    [Abstract] [Full Text] [Related]

  • 8. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I, Lee JH, Kutschera E, Winkler UH, Kuhl H.
    Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
    [Abstract] [Full Text] [Related]

  • 9. Antacid does not reduce the bioavailability of oral contraceptive steroids in women.
    Joshi JV, Sankolli GM, Shah RS, Joshi UM.
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):192-5. PubMed ID: 3086241
    [Abstract] [Full Text] [Related]

  • 10. Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use.
    Sänger N, Stahlberg S, Manthey T, Mittmann K, Mellinger U, Lange E, Kuhl H, Wiegratz I.
    Contraception; 2008 Jun; 77(6):420-5. PubMed ID: 18477491
    [Abstract] [Full Text] [Related]

  • 11. [The behavior of cytoplasmic progesterone receptors in the cycling endometrium and the effect of hormonal contraceptives].
    Carol W, Jäger R, Martin P, Möller U.
    Zentralbl Gynakol; 1989 Jun; 111(12):793-9. PubMed ID: 2763749
    [Abstract] [Full Text] [Related]

  • 12. The relative bioavailability of levonorgestrel and ethinylestradiol when administered in tablet and capsule form.
    Back DJ, Killick SR, Stevenson PJ, Shenoy N, Elstein M, Cohen M.
    Contraception; 1987 Sep; 36(3):321-6. PubMed ID: 3119288
    [Abstract] [Full Text] [Related]

  • 13. Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters.
    Wiegratz I, Stahlberg S, Manthey T, Sänger N, Mittmann K, Lange E, Mellinger U, Kuhl H.
    Contraception; 2008 Nov; 78(5):384-91. PubMed ID: 18929735
    [Abstract] [Full Text] [Related]

  • 14. Estradiol valerate/dienogest: a novel combined oral contraceptive.
    Borgelt LM, Martell CW.
    Clin Ther; 2012 Jan; 34(1):37-55. PubMed ID: 22169052
    [Abstract] [Full Text] [Related]

  • 15. [Rationale for prescribing oral contraceptives].
    Teichmann AT.
    Wien Med Wochenschr; 1998 Jan; 148(7):171-4. PubMed ID: 9700865
    [Abstract] [Full Text] [Related]

  • 16. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P, Trapnell CB, Ette E, Zacur HA, Coresh J, Rocco LE, Hendrix CW, Flexner C.
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [Abstract] [Full Text] [Related]

  • 17. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W.
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [Abstract] [Full Text] [Related]

  • 18. Comparative pharmacokinetics of levonorgestrel and ethinyloestradiol following intravenous, oral and vaginal administration.
    Back DJ, Grimmer SF, Rogers S, Stevenson PJ, Orme ML.
    Contraception; 1987 Oct; 36(4):471-9. PubMed ID: 3127114
    [Abstract] [Full Text] [Related]

  • 19. [Effect of ethinyl estradiol-dienogest combination on serum androgen concentrations].
    Oettel M, Carol W, Gräser T, Klinger G, Mellinger U, Moore C, Schindler AE, Winkler UH.
    Zentralbl Gynakol; 1997 Oct; 119(12):597-606. PubMed ID: 9483810
    [Abstract] [Full Text] [Related]

  • 20. Observations with anteovin "step-up" contraceptive tablet in young women.
    Takács G, Hámori M.
    Ther Hung; 1986 Oct; 34(3):150-4. PubMed ID: 3441877
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.